Current Clinical Trials for Colon/Colorectal/Rectal

CALGB 80405 - A Phase III Trial Of Irinotecan/5-Fu/Leucovorin or Oxaliplatin/5-Fu/Leucovorin With Bevacizumab, Or Cetuximab (C225), or With the Combination of Bevacizumab And Cetuximab For Patients with Untreated Metastatic Adenocarcinoma of The Colon Or Rectum

RTOG 0822 - A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) In Combination with Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

Email this Page                                                                     Print this Page